MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 226 filers reported holding MYRIAD GENETICS INC in Q4 2016. The put-call ratio across all filers is 9.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $29,258,000 | -22.5% | 1,755,099 | -4.3% | 0.00% | -33.3% |
Q3 2016 | $37,761,000 | -32.7% | 1,834,859 | +0.1% | 0.01% | -33.3% |
Q2 2016 | $56,099,000 | -19.7% | 1,833,291 | -1.7% | 0.01% | -25.0% |
Q1 2016 | $69,823,000 | -7.2% | 1,865,430 | +7.0% | 0.01% | 0.0% |
Q4 2015 | $75,278,000 | +20.0% | 1,744,164 | +4.2% | 0.01% | +9.1% |
Q3 2015 | $62,729,000 | +6.6% | 1,673,660 | -3.3% | 0.01% | +22.2% |
Q2 2015 | $58,836,000 | -11.3% | 1,730,967 | -7.6% | 0.01% | -10.0% |
Q1 2015 | $66,309,000 | +1.8% | 1,873,135 | -2.0% | 0.01% | 0.0% |
Q4 2014 | $65,126,000 | -9.4% | 1,912,109 | +2.6% | 0.01% | -16.7% |
Q3 2014 | $71,889,000 | -1.4% | 1,863,855 | -0.5% | 0.01% | 0.0% |
Q2 2014 | $72,875,000 | +13.0% | 1,872,432 | -0.8% | 0.01% | +9.1% |
Q1 2014 | $64,515,000 | +41.9% | 1,886,961 | -13.0% | 0.01% | +37.5% |
Q4 2013 | $45,478,000 | -3.0% | 2,167,690 | +8.7% | 0.01% | -11.1% |
Q3 2013 | $46,884,000 | -16.5% | 1,995,056 | -4.6% | 0.01% | -18.2% |
Q2 2013 | $56,164,000 | – | 2,090,221 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |